Lidocaine and Prilocaine cream is indicated as a topical anaesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery and as pretreatment ...

Meanwhile, Zydus Pharmaceuticals recalled 4,404 40 mg single-dose packets of the acid reflux treatment esomeprazole magnesium due to a labeling issue. The product, which was produced in India ...

Dec 18 (Reuters) - Merck (MRK.N), opens new tab has signed a licensing deal worth up to $2 billion for Chinese biotech Hansoh Pharma's (3692.HK), opens new tab experimental oral drug to treat ...

India has been traditionally quite strong in the pharma sector, with a low cost of manufacturing (30%–35% lower than in the US and Europe), cost-efficient R&D (about 87% less than in developed markets ...

Bulk drug parks to promote the domestic production of essential drugs and Promotion of Research & Innovation in the Pharma and MedTech sector (PRIP) scheme along with the promotion of AYUSH as an ...

Camylofin Market 2024 Camylofin Market is estimated to be valued at USD 185.1 Mn in 2024 and is expected to reach USD 261.2 Mn by 2031, growing at a CAGR of 5% from 2024 to 2031. BURLINGAME, CA, UNITE ...

Camylofin Market is estimated to be valued at USD 185.1 Mn in 2024 and is expected to reach USD 261.2 Mn by 2031, growing at a CAGR of 5% from 2024 to 2031. BURLINGAME, CA, UNITED STATES, December ...

New Delhi: USA-based subsidiaries of Aurobindo Pharma, Glenmark and Zydus are recalling products in the US over manufacturing issues. The said products are indicated for the treatment of ...

A team of researchers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) has now developed a groundbreaking genetic method that leverages a natural bacterial mechanism for the ...

Zydus Animal Health & Investments Limited ... The original transaction was a first of sorts, as it had brought together a pharmaceutical company, a diagnostics company, and a vaccine manufacturer.

Drug makers Aurobindo Pharma, Glenmark and Zydus are recalling products in the US market due to manufacturing issues, according to the US health regulator. As per the latest Enforcement Report of US ...

CHATHAM, N.J., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and ...